Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 130, 2024 - Issue 1
227
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

H2S-mediated blockage of protein acetylation and oxidative stress attenuates lipid overload-induced cardiac senescence

, , &
Pages 96-109 | Received 20 Jul 2021, Accepted 30 Aug 2021, Published online: 11 Sep 2021

References

  • Ali, A., et al., 2020. Cystathionine gamma-lyase/H2S system suppresses hepatic acetyl-CoA accumulation and nonalcoholic fatty liver disease in mice. Life sciences, 252, 117661.
  • Attene-Ramos, M.S., et al., 2010. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environmental and molecular mutagenesis, 51 (4), 304–314.
  • Banerjee, D., et al., 2020. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy. Journal of molecular and cellular cardiology, 139, 148–163.
  • Bouter, K.E.C., et al., 2020. The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterol. Diabetes, obesity & metabolism, 22 (6), 988–996.
  • Das, A., et al., 2018. Impairment of an endothelial NAD+-H2S signaling network is a reversible cause of vascular aging. Cell, 173 (1), 74–89.e20.
  • Du, C., et al., 2019. Sulfhydrated sirtuin-1 increasing its deacetylation activity is an essential epigenetics mechanism of anti-atherogenesis by hydrogen sulfide. Antioxidants & redox signaling, 30 (2), 184–197.
  • Elrod, J.W., et al., 2007. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proceedings of the National Academy of Sciences of the United States of America, 104 (39), 15560–15565.
  • Gerő, D., et al., 2016. The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. Pharmacological research, 113 (Pt A), 186–198.
  • Guan, R., et al., 2019. Hydrogen sulfide attenuates mitochondrial dysfunction-induced cellular senescence and apoptosis in alveolar epithelial cells by upregulating sirtuin 1. Aging, 11 (24), 11844–11864.
  • Guo, R., et al., 2017. New mechanism of lipotoxicity in diabetic cardiomyopathy: deficiency of endogenous H2S production and ER stress. Mechanisms of ageing and development, 162, 46–52.
  • Hebert, A.S., et al., 2013. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Molecular cell, 49 (1), 186–199.
  • Hemanthakumar, K.A., et al., 2021. Cardiovascular disease risk factors induce mesenchymal features and senescence in mouse cardiac endothelial cells. Elife, 10, e62678.
  • Hirschey, M.D., et al., 2010. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature, 464 (7285), 121–125.
  • Jeddi, S., et al., 2020. Protective effect of intermediate doses of hydrogen sulfide against myocardial ischemia-reperfusion injury in obese type 2 diabetic rats. Life sciences, 256, 117855.
  • Jin, S., et al., 2015. Cardiac H2S generation is reduced in ageing diabetic mice. Oxidative medicine and cellular longevity, 2015, 758358.
  • Johnson, R., et al., 2017. The transcription profile unveils the cardioprotective effect of aspalathin against lipid toxicity in an in vitro H9c2 model. Molecules, 22, 219.
  • Kar, S., et al., 2019. Exercise training promotes cardiac hydrogen sulfide biosynthesis and mitigates pyroptosis to prevent high-fat diet-induced diabetic cardiomyopathy. Antioxidants, 8, 638.
  • Karunakaran, D., et al., 2015. Therapeutic inhibition of miR-33 promotes fatty acid oxidation but does not ameliorate metabolic dysfunction in diet-induced obesity. Arteriosclerosis, thrombosis, and vascular biology, 35 (12), 2536–2543.
  • Kondo, K., et al., 2013. H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation, 127 (10), 1116–1127.
  • Latorre, E., et al., 2018. Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors HNRNPD and SRSF2. Aging, 10 (7), 1666–1681.
  • Li, H., et al., 2015. Mediation of exogenous hydrogen sulfide in recovery of ischemic post-conditioning-induced cardioprotection via down-regulating oxidative stress and up-regulating PI3K/Akt/GSK-3β pathway in isolated aging rat hearts. Cell & bioscience, 5, 11.
  • Libiad, M., et al., 2019. Hydrogen sulfide perturbs mitochondrial bioenergetics and triggers metabolic reprogramming in colon cells. The journal of biological chemistry, 294 (32), 12077–12090.
  • Lopaschuk, G.D., et al., 2021. Cardiac energy metabolism in heart failure. Circulation research, 128 (10), 1487–1513.
  • Miller, E.J., et al., 2015. Partial Liver kinase B1 (LKB1) deficiency promotes diastolic dysfunction, de novo systolic dysfunction, apoptosis, and mitochondrial dysfunction with dietary metabolic challenge. Journal of the American heart association, 5, e002277.
  • Módis, K., et al., 2016. S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics. Pharmacological research, 113 (Pt A), 116–124.
  • Moldogazieva, N.T., et al., 2019. Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases. Oxidative medicine and cellular longevity, 2019, 3085756.
  • Mustafa, A.K., et al., 2009. H2S signals through protein S-sulfhydration. Science signaling, 2 (96), ra72.
  • Nielsen, L.B., et al., 1999. The DNA sequences required for apolipoprotein B expression in the heart are distinct from those required for expression in the intestine. Journal of molecular and cellular cardiology, 31 (4), 695–703.
  • Papa, S., 1996. Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. Biochimica et biophysica acta, 1276 (2), 87–105.
  • Qabazard, B., and Stürzenbaum, S.R., 2015. H2S: a new approach to lifespan enhancement and healthy ageing? Handbook of experimental pharmacology, 230, 269–287.
  • Ren, X., et al., 2017. Resveratrol ameliorates mitochondrial elongation via Drp1/Parkin/PINK1 signaling in senescent-like cardiomyocytes. Oxidative medicine and cellular longevity, 2017, 4175353.
  • Sen, N., et al., 2012. Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions. Molecular cell, 45 (1), 13–24.
  • Shaw, B.F., et al., 2008. Lysine acetylation can generate highly charged enzymes with increased resistance toward irreversible inactivation. Protein science, 17 (8), 1446–1455.
  • Shi, L., and Tu, B.P., 2015. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Current opinion in cell biology, 33, 125–131.
  • Sun, H.J., et al., 2019. Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide. Frontiers in pharmacology, 10, 1568.
  • Sun, Y., et al., 2020. Exogenous H2S promoted USP8 sulfhydration to regulate mitophagy in the hearts of dB/dB mice. Aging and Disease, 11 (2), 269–285.
  • Truong, D.H., et al., 2006. Molecular mechanisms of hydrogen sulfide toxicity. Drug metabolism reviews, 38 (4), 733–744.
  • Wakabayashi, H., et al., 2019. Impact of body mass index on activities of daily living in inpatients with acute heart failure. The journal of nutrition, health & aging, 23 (2), 151–156.
  • Wang, R., 2012. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiological reviews, 92 (2), 791–896.
  • Wang, S.Y., et al., 2019. Methionine restriction delays senescence and suppresses the senescence-associated secretory phenotype in the kidney through endogenous hydrogen sulfide. Cell cycle, 18 (14), 1573–1587.
  • Wang, Y., et al., 2021. Hydrogen sulfide guards myoblasts from ferroptosis by inhibiting ALOX12 acetylation. Cellular signalling, 78, 109870.
  • Wong, C., and Marwick, T.H., 2007. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nature clinical practice cardiovascular medicine, 4 (8), 436–443.
  • Wu, W., et al., 2017. H2S donor NaHS changes the production of endogenous H2S and NO in D-galactose-induced accelerated ageing. Oxidative medicine and cellular longevity, 2017, 5707830.
  • Wu, Y., et al., 2016. Pax8 plays a pivotal role in regulation of cardiomyocyte growth and senescence. Journal of cellular and molecular medicine, 20 (4), 644–654.
  • Xia, H., et al., 2020. Endothelial cell cystathionine γ-lyase expression level modulates exercise capacity, vascular function, and myocardial ischemia reperfusion injury. Journal of the American heart association, 9 (19), e017544.
  • Xie, Z.Z., et al., 2014. Sulfhydration of p66Shc at cysteine59 mediates the antioxidant effect of hydrogen sulfide. Antioxidants & redox signaling, 21 (18), 2531–2542.
  • Yadav, P.K., et al., 2019. S-3-Carboxypropyl-l-cysteine specifically inhibits cystathionine γ-lyase-dependent hydrogen sulfide synthesis. The journal of biological chemistry, 294 (28), 11011–11022.
  • Yang, G., 2011. Hydrogen sulfide in cell survival: a double-edged sword. Expert review of clinical pharmacology, 4 (1), 33–47.
  • Yang, G., et al., 2008. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science, 322 (5901), 587–590.
  • Yu, M., et al., 2020. Exogenous H2S induces Hrd1 S-sulfhydration and prevents CD36 translocation via VAMP3 ubiquitylation in diabetic hearts. Aging and disease, 11 (2), 286–300.
  • Zhang, Y., et al., 2020. Golgi stress response, hydrogen sulfide metabolism, and intracellular calcium homeostasis. Antioxidants & redox signaling, 32 (9), 583–601.
  • Zhang, Y.E., et al., 2019. Hydrogen sulfide protects H9c2 cardiomyoblasts against H2O2-induced apoptosis. Brazilian journal of medical and biological research, 52 (4), e7626.
  • Zivanovic, J., et al., 2019. Selective persulfide detection reveals evolutionarily conserved antiaging effects of S-sulfhydration. Cell metabolism, 30 (6), 1152–1170.e13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.